Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
3.0
-52.06%
20%
—
-95.05%
80%
—
5 Years
Score3.0
Net Growth-52.06%
Net Trend20%
Net Income Consistency—
Rev Growth-95.05%
Rev Trend80%
Revenue Consistency—
Silence Therapeutics PLC fundamental performance
Between 2020 and 2025, revenue declined from £ 5M to £ 559K and net income went from -£ 32M to -£ 88M. Revenue increased in 4 of those 5 years; net income in 1.
Silence Therapeutics PLC currently holds a 5-year HDB Score of 3.0 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 13.58 | — |
1 Year2025-08-12 | $ 5.59 | 142.93% |
5 Years2021-08-12 | $ 25.73 | -47.22% |
All Time2020-09-08 | $ 19.50 | -30.36% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2020-09-08 |
|---|---|---|---|---|
| Price | $ 13.58 | $ 5.59 | $ 25.73 | $ 19.50 |
| Return | — | 142.93% | -47.22% | -30.36% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | £ 614.29K | -£ 59M | £ 72M |
| 2025 | £ 559K | -£ 88M | £ 85M |
| 2024 | £ 43M | -£ 45M | £ 117M |
| 2023 | £ 25M | -£ 43M | £ 68M |
| 2022 | £ 17M | -£ 41M | £ 71M |
| 2021 | £ 12M | -£ 39M | £ 73M |
| IPO2020 | £ 5M | -£ 32M | £ 37M |
Explore beyond SLN
You're looking at Silence Therapeutics PLC. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
